Insight Into the Molecular Basis of Pathogen Abundance: Group A Streptococcus Inhibitor of Complement Inhibits Bacterial Adherence and Internalization Into Human Cells
Document Type
Article
Journal/Book Title/Conference
Proceedings of the National Academy of Sciences of the United States of America
Volume
99
Publication Date
2002
Abstract
Streptococcal inhibitor of complement (Sic) is a secreted protein made predominantly by serotype M1 Group A Streptococcus (GAS), which contributes to persistence in the mammalian upper respiratory tract and epidemics of human disease. Unexpectedly, an isogenic sic-negative mutant adhered to human epithelial cells significantly better than the wild-type parental strain. Purified Sic inhibited the adherence of a sicnegative serotype M1 mutant and of non-Sic-producing GAS strains to human epithelial cells. Sic was rapidly internalized by human epithelial cells, inducing cell flattening and loss of microvilli. Ezrin and moesin, human proteins that functionally link the cytoskeleton to the plasma membrane, were identified as Sic-binding proteins by affinity chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis. Sic colocalized with ezrin inside epithelial cells and bound to the F-actin-binding site region located in the carboxyl terminus of ezrin and moesin. Synthetic peptides corresponding to two regions of Sic had GAS adherence-inhibitory activity equivalent to mature Sic and inhibited binding of Sic to ezrin. In addition, the sic mutant was phagocytosed and killed by human polymorphonuclear leukocytes significantly better than the wild-type strain, and Sic colocalized with ezrin in discrete regions of polymorphonuclear leukocytes. The data suggest that binding of Sic to ezrin alters cellular processes critical for efficient GAS contact, internalization, and killing. Sic enhances bacterial survival by enabling the pathogen to avoid the intracellular environment. This process contributes to the abundance of M1 GAS in human infections and their ability to cause epidemics.
Recommended Citation
Hoe, N.P., Ireland, R.M., Deleo, F.R., Gowen, B.B., Dorward, D.W., Voyich, J.M., Liu, M., Burns, Jr., E.H., Culnan, D.M., Bretscher, A. and Musser, J.M. Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc. Nat. Acad. Sci. USA (2002) 99, 7646-51.
Comments
Proc. Nat. Acad. Sci. USA (2002) 99, 7646-51